International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aortic Valve Platform
A legfontosabb adatok
- Ki végzi
- IRCCS Policlinico S. Donato
- Hol
- San Donato Milanese (Olaszország)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 1000 fő, tervezett
- Kezdés
- 2025. okt. 11.
- Várható befejezés
- 2031. okt.
- A vizsgálat típusa
- Megfigyeléses
- A regiszteradat frissítve
- 2026. július 24.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with severe aortic stenosis that causes symptoms. Their heart team must have chosen them for a TAVI (valve replaced through a tube in a blood vessel) with the Navitor/Navitor Vision valve.
- Életkor
- 18 Years and older (legal age for consent in the host country).
- Nem
- All
- A betegség stádiuma
- Severe aortic stenosis (narrowed heart valve) that causes symptoms, in the person's own valve or in an earlier surgical tissue valve.
A részvétel fő kizáró okai
- Pregnant or breastfeeding
- Need for emergency surgery for any reason
- Infection of the blood (sepsis), including active infection of the heart lining, or a blood clot in the heart
- A valve without three leaflets, a valve ring without calcium, or blood vessels that make access impossible
- Cannot take blood-thinning or anti-platelet medicine, or unable to give consent, read or write
A regiszter feltételei, szó szerint
Mind a 8 feltétel megnézéseKevesebb
Ki vehet részt
- Subject is referred to undergo TAVI with a Navitor/Navitor Vision valve according to the local Heart Team. The Heart Team determines the indication for TAVI with Navitor/Navitor Vision before possible enrolment and independently of the study
- Subject is of legal age for consent in the host country
- Subject has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent as approved by the Ethics Committee (EC) of the respective clinical site
Ki nem vehet részt
- Need for emergency surgery for any reason
- Contraindications to Navitor/Navitor Vision TAVI according to the IFU:; Any sepsis, including active endocarditis; Any evidence of left ventricular or atrial thrombus; Vascular conditions (i.e., stenosis, tortuosity, or severe calcification) that make insertion and endovascular access to the aortic valve impossible; Non-calcified aortic annulus; Any leaflet configuration other than tricuspid; Inability to tolerate antiplatelet/anticoagulant therapy
- Incapacitated individuals, defined as persons who are mentally ill, mentally handicapped, individuals with severe dementia or individuals without legal authority
- Pregnant or nursing subjects
- Individuals who are unable to read or write
Helyszínek itt: Olaszország
- IRCCS Policlinico San DonatoSan Donato Milanese, OlaszországContact: Luca Testa, Principal InvestigatorRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
INTENSIVE is a prospective, single-arm, multi-center, international, investigator-initiated study of the Navitor/Navitor Vision Transcatheter Aortic Valve (Navitor/Navitor Vision Valve) in patients with symptomatic, severe native aortic stenosis to monitor the outcomes of this valve in a real-world clinical setting.
A vizsgálat csoportja
- Aortic Stenosis Patients
This Study will enroll subjects of all genders who have symptomatic severe AS, either in a native valve or in a surgical bioprosthetic valve, and who have an indication for TAVI. The latter may also be predominantly regurgitant and remain suitable for enrolment. Subjects must meet all general eligibility criteria for the TAVI procedure and provide written informed consent before sites collect any clinical data for this Study. The operative risk determination of study candidates will be done by the local heart team. The assessment of surgical risk will include the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Risk Calculator score and/or EuroSCORE II, indices of frailty, and comorbidities not captured by risk calculators, as described below, and current TAVI practice guidelines.
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aortic Valve Platform (The Intensive Study)
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. július 24.